Mr Mojdeh was formerly vice president and general manager of Becton Dickinson (BD) Pharmaceutical Systems, North America, and worldwide vice president of research and development of BD Medical.

Mr Mojdeh has more than 25 years of business leadership experience across multiple industries, including 18 years in the design, development, manufacturing, sales and marketing of therapeutic and diagnostic medical devices for several multinational companies, including BD, GE Healthcare and Boston Scientific (formerly Guidant Corporation).

Mr Mojdeh has developed and maintained strong relationships with many pharmaceutical manufacturers that utilize prefilled syringes for their injectable drugs and vaccines.

As COO, Mr Mojdeh will lead Unilife's operating team as the company prepares to enter its next phase of business expansion with the commercial production of the Unifill ready-to-fill (prefilled) syringe this quarter, and its supply to pharmaceutical customers.

Mr Mojdeh will also help to expand and accelerate discussions with pharmaceutical companies regarding the Unifill syringe, as well as the commercialization of a number of key pipeline products being developed by the company.

Mr Mojdeh spent the last eight years working with BD including prefilled syringes. He served as the vice president and general manager of BD Medical, Pharmaceutical Systems, North America from 2008 to 2010.

In this role, Mr Mojdeh directed all aspects of the North America operations including sales, marketing, business development, commercial development, finance, R&D, manufacturing, operations, quality assurance, regulatory affairs, legal affairs and human resources.

From 2002 to 2008, Mr Mojdeh held the position of the worldwide vice president of research and development for BD Medical, responsible for technology and product innovation and commercialization for the business areas of medical surgical systems, diabetes care, pharmaceutical systems and ophthalmic systems with combined annual revenues of over $4 billion. During this time, he led the process of revamping the product development functions for BD Medical.

Mr Mojdeh was also a board member of BD Ventures, the venture capital arm of BD, which oversaw all technology and innovation activities across BD. Furthermore, he has served as the chairman of the Advanced Drug Delivery Council, aimed at identifying and developing new growth strategies in the drug delivery device space.

Prior to his work with BD, Mr Mojdeh held the position of business director of invasive cardiology at GE Healthcare in 2002, and spent ten years with Guidant Corporation, where he held several management positions including business director, advanced patient management from 1999 to 2002 and business director, advanced patient monitoring system from 1996 to 1999.

Alan Shortall, CEO of Unilife, said: “The addition of Mr Mojdeh to our executive team and as the leader of our operational divisions is a clear indication of Unilife's commitment to rapid growth and the production of the highest quality medical devices.”

Will Mr Mojdeh's experience benefit the firm?

Have your say and discuss with your peers on the InfoGrok community.

Participate by posting your comments now.